AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00780260 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: strengths-based case management
Description: 5 session individual strengths-based case management; peer-involvement v. no peer involvement
Study NCT01355159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Folic Acid 4 mg
Description: Folic Acid 1.0 mg or placebo x 4 tablets will be taken daily by oral administration. The majority of women in the study will routinely take 1.0 mg folic acid in a prenatal vitamin supplement, as recommended by their primary obstetrical provider; the study requirements do not require that participants change their practice. Therefore the actual total daily dose may be up to 5.1 mg of folic acid
Study NCT01355159 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo x 4 tablets will be taken daily by oral administration.
Study NCT03964519 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acute changes
Description: In a crossover design, participants will be randomized to perform on Day 1, 3 sets of repetitions (depending on each treatment group) at 70% or 1RM in the full squat exercise. 48-h later, same will be performed but in the contrary crossover arm.
Study NCT03964519 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chronic changes
Description: In a randomized control trial, participants will train during 6 weeks the full squat exercise, 2 days in the week (minimum between-days rest of 48h). Intensity will vary from 70% to 85 of 1RM, and training volume from 3 to 6 sets.
Study NCT03964519 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Chronic changes
Description: In a randomized control trial, participants will train during 6 weeks the full squat exercise, 2 days in the week (minimum between-days rest of 48h). Intensity will vary from 70% to 85 of 1RM, and training volume from 3 to 6 sets.
Study NCT03964519 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Familiarization
Description: Prior to any intervention, all participants will perform a familiarization of the exercise session, together with a progressive resistance test to estimate the 1 RM
Study NCT03964519 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Familiarization
Description: Prior to any intervention, all participants will perform a familiarization of the exercise session, together with a progressive resistance test to estimate the 1 RM
Study NCT00854802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Debio 025
Description: Debio 025 supplied in soft gel capsules
Study NCT00854802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peg-IFNα2a
Description: Peg-IFNα2a supplied in pre-filled syringes
Study NCT00854802 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Peg-IFNα2a
Description: Peg-IFNα2a supplied in pre-filled syringes
Study NCT00854802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribavirin
Description: Ribavirin supplied in tablets
Study NCT00854802 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ribavirin
Description: Ribavirin supplied in tablets
Study NCT00854802 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Debio 025 placebo
Description: Debio 025 placebo supplied in soft gel capsules
Study NCT01051180 — intervention group
Intervention type: PROCEDURE
Intervention: HALO
Description: Ligation of haemorrhoidal arteries
Study NCT00754442 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teriparatide
Description: Teriparatide will be given by continuous intravenous infusion at a rate of 12 pmol/kg/hr for 8 hours to both patients and controls
Study NCT00754442 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Teriparatide
Description: Teriparatide will be given by continuous intravenous infusion at a rate of 12 pmol/kg/hr for 8 hours to both patients and controls
Study NCT01976455 — intervention group
Intervention type: OTHER
Intervention: 20% fewer calories
Study NCT01976455 — intervention group
Intervention type: OTHER
Intervention: 40% fewer calories
Study NCT02715219 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Asthma Education Programme
Description: The Asthma Education Programme consists of four items. 1. Education video for Asthmatic patient adapted from Info Sehat by Bahagian Pendidikan Kesihatan Kementerian Kesihatan Malaysia which is explaining about Asthma disease, medication and patient responsibility in Asthma management. 2. Small group discussion with subject's to help them understand better in Asthma management. 3. Face to face demonstration and teaching of inhaler technique by three trained nurse in small group range of two to five subjects. At the end of the AEP subject will received a 4. Pamphlet will be obtain from Patients' Education Unit in Ampang Hospital containing vital information about Asthma disease and management. The intervention estimated will take 1 hour to 1 hour 30 minutes to be completed.
Study NCT03693534 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Clinical Pregnancy Rate
Description: The Clinical Pregnancy, Live Birth Rate and Blastulation Rate according to the protocol of COS
Study NCT04645979 — intervention group
Intervention type: OTHER
Intervention: Online survey
Description: Participants will be invited to complete an online questionnaire about their experience of product use.
Study NCT04026373 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: modified Prolonged Exposure
Study NCT04026373 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: May include consult to health psychology and any follow-up deemed appropriate
Study NCT00711841 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: dexamethasone
Description: Dexamethasone, 10mg (2mL), intravenous, every 12 hours, for 48 hours
Study NCT00711841 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline solution, 2 mL, intravenous, every 12 hours, for 48 hours
Study NCT00211913 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: S. aureus Type 5 & 8 Capsular Polysaccharide Conjugate
Description: single IM dose totalling 200 mcg of conjugate
Study NCT00211913 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: single IM dose
Study NCT00006505 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Islet Transplantation
Description: Islet cell transplantation. This study will test whether a new islet transplant procedure will enable patients with type 1 diabetes mellitus to stop insulin therapy
Study NCT02320123 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational DVD
Description: African American patients and their primary non-professional caregivers will watch a DVD created to introduce end-of-life care planning to African Americans receiving palliative care.
Study NCT04293705 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Teen On-line Problem Solving
Description: The TOPS program is a web-based platform delivered on computers and tablets, which is composed of different self-guided, online sessions on different contents: executive functions, social skills, behavioral strategies, injury-related issues and health and wellness. The TOPS program has been designed to be performed by patients and their families at home. Biweekly Google Meet videoconferences between a coach with expertise in cognitive-behavioral psychotherapy and patients are scheduled along the entire duration of the program.
Study NCT04293705 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Teen On-line Problem Solving
Description: The TOPS program is a web-based platform delivered on computers and tablets, which is composed of different self-guided, online sessions on different contents: executive functions, social skills, behavioral strategies, injury-related issues and health and wellness. The TOPS program has been designed to be performed by patients and their families at home. Biweekly Google Meet videoconferences between a coach with expertise in cognitive-behavioral psychotherapy and patients are scheduled along the entire duration of the program.
Study NCT02278393 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 1-Fermented Dairy Product with Phytosterols (test)
Description: 1- 3 bottles of test product/day
Study NCT02278393 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 2-Fermented dairy Product with No Phytosterols (control)
Description: 2-3 bottles of control product/day
Study NCT03153735 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CMDHA0101
Description: Maximum injection dose : 22 ml
Study NCT03153735 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PowerFill®
Description: Maximum injection dose : 22 ml
Study NCT03579953 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Real cTBS
Description: This will be delivered with the Magventure Magpro system; 3600 pulses with the active sham coil (double blinded using the USB key).
Study NCT03579953 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham cTBS
Description: This will be delivered with the sham Magventure Magpro system; 3600 pulses with the active sham coil (double blinded using the USB key). The MagVenture MagPro system has an integrated active sham that passes current through two surface electrodes placed on the skin beneath the B60 coil.
Study NCT01263691 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: BioThrax
Description: BioThrax
Study NCT01263691 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AV7909 Formulation 1
Description: AV7909 Formulation 1
Study NCT01263691 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AV7909 Formulation 2
Description: AV7909 Formulation 2
Study NCT01263691 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AV7909 Formulation 3
Description: AV7909 Formulation 3
Study NCT01263691 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AV7909 Formulation 4
Description: AV7909 Formulation 4
Study NCT01263691 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Saline control
Study NCT03990519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-26366821
Description: Participants will receive sterile solution of JNJ-26366821 subcutaneously (SC).
Study NCT01681472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 6R-MTHF (arfolitixorin) 200 mg/m2
Description: i.v. bolus injection
Study NCT01681472 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levoleucovorin 200 mg/m2
Description: i.v. bolus injection
Study NCT03990519 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will receive sodium chloride injection as placebo on Day 1.
Study NCT03319615 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary energy restriction
Study NCT01188564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rhC1INH
Description: One i.v. injection of rhC1INH at the dose of 50 U/kg, for patients up to 84 kg; one i.v. injection of rhC1INH at the dose of 4200U (2 vials) for patients of 84 kg body weight or greater.
Study NCT01188564 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (Saline)
Description: One i.v. injection of saline (NaCl 0.9% w/v), equivalent in volume to the active treatment
Study NCT00711841 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexamethasone
Description: dexamethasone, 10mg, 2 mL, intravenous solution, every 12 hours , for 48 hours
Study NCT01681472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 6R-MTHF (arfolitixorin) 60 mg/m2
Description: i.v. bolus injection
Study NCT01681472 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levoleucovorin 60 mg/m2
Description: i.v. bolus injection
Study NCT03893734 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: methadone
Description: Patients in the methadone group will receive a syringe of methadone at induction of anesthesia and a syringe of saline at the end of anesthesia
Study NCT03893734 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Hydromorphone
Description: Patients in the hydromorphone group will receive a syringe of saline at induction of anesthesia and a syringe of hydromorphone at the end of anesthesia
Study NCT02433119 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OROSARTAN® 5/160mg
Study NCT02433119 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: CODIOVAN® 160/12.5mg
Study NCT02709161 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: real-time fMRI neurofeedback: HIPS
Description: Participants are shown activity from their left horizontal segment of the intraparietal sulcus in real time and are instructed to increase the level of activity in that region by thinking of positive autobiographical memories
Study NCT04531917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education
Description: Pain Neuroscience Education (PNE) teaches patients about complex pain mechanisms known to be of importance in pain following breast cancer such as malfunctioning of the endogenous analgesic system and pain memories.
Study NCT04531917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Behavioural Graded Activity
Description: Patients in the experimental group will receive a behavioural treatment integrated within the concepts of operant conditioning. The purpose of Behavioural Graded Activity (BGA) is to increase the level of physical activity in the patient's daily lives in a time-contingent manner. On top of that, a healthy behaviour will be positively reinforced to consequently create a withdrawal of the attention towards pain behaviour, which is seen as an unreliable alarm sign in chronic pain patients. The implementation of BGA after PNE is described in the guideline reported by the International Association for the Study of Pain.
Study NCT03135652 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: adjuvant SBRT
Description: adjuvant SBRT of liver lesions
Study NCT04209777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Probiotic Blend Chewable Tablet
Description: Lactobacillus-reuteri probiotics were used as an experimental drug.
Study NCT04531917 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: The content of the leaflet has a biomedical approach in explaining pain and providing information on the different pain medication classes. This leaflet is mostly available in waiting rooms of oncology centres and units of the Flemish part of Belgium.
Study NCT00677729 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: solution contains 1 mg salbutamol plus 3% hypertonic saline
Description: 4 ml of nebulized study solution containing 1 mg salbutamol plus 3% hypertonic saline every 20 minutes for a total of 3 doses
Study NCT00677729 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: solution contains 1 mg salbutamol plus 0.9% saline
Description: 4 ml of nebulized study solution containing 1 mg salbutamol plus 0.9% saline (NaCl) every 20 minutes for a total of 3 doses
Study NCT01217801 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ondansetron (ODFS)
Description: Ondansetron Orally Dissolving Filmstrip Ondansetron (ODFS)
Study NCT01217801 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ondansetron (ODT)
Description: Ondansetron Orally Disintegrating Tablet Ondanestron (ODT)
Study NCT02367443 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation
Description: Radiation: Accelerated Hypofractionated radiotherapy with full dose Chemotherapy
Study NCT00478231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maraviroc
Description: Maraviroc should be dosed BID with total dose adjusted according to the other drugs the patient is taking. Maraviroc may be taken with or without food. The subject should only take missed doses if it is not within 6 hours prior to the planned next dose. No dose adjustment of OBT is required due to the presence of maraviroc.
Study NCT03135652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: mFolfox6/ CAPEOX/ Folfiri±cetuximab or bevacizumab, 2 months for neoadjuvant treatment and 4 months for adjuvant treatment
Study NCT03135652 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: mFolfox6/ CAPEOX/ Folfiri±cetuximab or bevacizumab, 2 months for neoadjuvant treatment and 4 months for adjuvant treatment
Study NCT04092400 — intervention group
Intervention type: DEVICE
Intervention: Micro-invasive Glaucoma Surgical Devices
Description: Safety and efficacy of Micro-invasive Glaucoma Surgical Devices
Study NCT04136418 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: COPDPredict mobile App
Description: An App on a mobile device is used by the patient to track the status of their COPD and inform the patient's care team
Study NCT04136418 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Patients self-manage their COPD using prescribed medication in accordance with basic guidance information
Study NCT03136354 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic Submucosal Dissection
Study NCT03136354 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic assisted Gastrectomy
Study NCT03566160 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryobiopsy probe, administered to study participants
Description: Cryobiopsy probe as a tool for gastrointestinal biopsy
Study NCT01209611 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow mononuclear cells
Description: Autologous bone marrow-derived mononuclear cells, after isolated by density gradient centrifugation from bone marrow aspiration and resuspended in saline, will be transplanted subcutaneously to expanded skin. The number of infused cells will be 1x10e6/cm2.
Study NCT01167517 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instructional digital video disc (DVD)
Description: Breast milk expression instructions provided by digital video disc at the time of hospital discharge
Study NCT01167517 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Instructional digital video disc (DVD)
Description: Breast milk expression instructions provided by digital video disc at the time of hospital discharge
Study NCT01208428 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional cognitive behavioral therapy
Description: Conventional cognitive behavioral therapy is a standard treatment for depression. There will be ten 50-minute sessions delivered.
Study NCT01208428 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Religious cognitive behavioral therapy
Description: Religious cognitive behavioral therapy is conventional cognitive behavioral therapy that includes consideration of the patient's religious beliefs in therapy. Subjects will receive ten 50-min sessions of therapy
Study NCT01597479 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Description: In dPNBs group, we performed ultrasound guided dPNBs on radial and median nerves using low concentration and low volume of long acting local anesthetic (0.125% levobupivacaine, 5 ml per nerve). Using low concentrations of levobupivacaine on target nerves could achieve a prolonged sensitive block in the surgical area without motor block of the hand.
Study NCT01944787 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine
Description: IV Hydration at 125 cc hour
Study NCT01944787 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IV Hydration at 250cc hour
Description: IV Hydration at 250 cc hour
Study NCT04977661 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin E
Description: Vitamin E is one of the body's most effective chain-breaking antioxidants that has shown to delay the pathogenesis of NASH.
Study NCT04977661 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ursodeoxycholic acid
Description: is a metabolic by-product of intestinal bacteria and has been proven to be useful in the non-surgical treatment of cholesterol gallstones and primary biliary cirrhosis (PBC)
Study NCT04977661 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pentoxifylline
Description: it is a well-tolerated medication that improves blood~viscosity and erythrocyte rheological characteristics in individuals with peripheral vascular disease 20. In addition, PTX is a nonspecific phosphodiesterase inhibitor that increases cyclic adenosine monophosphate (cAMP) levels while decreasing TNF-a gene transcription
Study NCT03432832 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EASE
Description: Weekly behavioral sessions with therapist to work on emotional control through measures such as mindfulness.
Study NCT03432832 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supportive Therapy
Description: Weekly behavioral sessions with a therapist to work on emotional control
Study NCT03704207 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: nNO testing
Description: Collection of already performed clinical data and nNO testing
Study NCT04107233 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Audit and Feedback
Description: Charts for enrolled physicians will be audited and they will receive feedback, consisting of tailored reports and one-on-one meeting with colleague to review at baseline, 3 months and 6 months
Study NCT04209777 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Antibiotics
Description: Amoxicillin capsules 500mg and metronidazole tablets 400mg antibiotics were used as an active comparator.